Regulation & Policy
FDA draft guidance sets lifecycle expectations for AI-enabled device software functions
The FDA's draft guidance lays out total-product-lifecycle and marketing-submission expectations for AI-enabled medical devices, emphasizing transparency, bias mitigation, cybersecurity, and post-market change management.